Cost-effectiveness of prehospital versus inhospital thrombolysis in acute myocardial infarction;Custo-efetividade da trombólise pré-hospitalar vs intra-hospitalar no infarto agudo do miocárdio

Arquivos Brasileiros de Cardiologia

Volumn 90, Issue 2, 2008, Pages

  Araújo, Denizar Vianna ^a,d   Tura, Bernardo Rangel ^b   Brasileiro, Antonio Luiz ^b   Neto, Heitor Luz ^b   Pavão, Ana Luiza Braz ^c   Teich, Vanessa ^c  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b MINISTÉRIO DA SAÚDE   (Brazil)

^c MedInsight   (Brazil)

^d NONE   (Brazil)

Author keywords

Cost effectiveness evaluation; Myocardial infarction; Thrombolytic therapy

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ELECTROCARDIOGRAM; HEART SCINTISCANNING; HOSPITALIZATION COST; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; NATIONAL HEALTH SERVICE;

ACUTE DISEASE; BRAZIL; DECISION TREES; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; LIFE EXPECTANCY; MYOCARDIAL INFARCTION; NATIONAL HEALTH PROGRAMS; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 42049115248     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008000200005     Document Type: Article

References (19)

1. Fibrinolitic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994; 343: 311-22.
2. Wallentin L. Reducing time to treatment in acute myocardial infarction. Eur J Emerg Med. 2000; 7 (3): 217-27.
3. Ministério da Saúde/SVS - Sistema de Informaçõ es de Mortalidade (SIM) e IBGE 2003. [acesso em 2007 jan 17]. Disponível em: http://www.datasus.gov.br..
4. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA. 2000; 283 (20): 2686-92.
5. Brasileiro AL. SAMU-192 and the prehospital approach to acute myocardial infarction in Brazil: hope for patients or one more missed opportunity? Arq Bras Cardiol. 2007; 88 (2): e44-6.
6. Hunink MGM, Glasziou PP. Decision making in health and medicine: integrating the evidence and values. London: Cambridge University Press; 2001.
7. Vale L, Steffens H, Donaldson C. The costs and benefits of community thrombolysis for acute myocardial infarction: a decision-analytic model. Pharmacoeconomics. 2004; 22 (14): 943-54.
8. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: grampian region early anistreplase trial. GREAT Group. BMJ. 1992; 305 (6853): 548-53.
9. Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AAJ, Arntz HR, et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation. 2003; 108 (2): 135-42.
10. Sociedade Brasileira de Cardiologia. III Diretriz Sobre Tratamento do Infarto Agudo do Miocárdio. Arq Bras Cardiol. 2004; 83 (supl 4): 3-86.
11. Ministério da Saúde. Banco de preços do Ministério da Saúde. [Acesso em 2007 jan 17]. Disponível em http://dtr2001.saude.gov.br/banco/..
12. Secretaria da Saúde do Estado da Bahia (SESAB). APH móvel - SAMU. Projeto de reorganização do atendimento de urgências e emergências para o Estado da Bahia. [Acesso em 2007 jan 17]. Disponível em http://www.saude.ba.gov.br/samu/PDR%20e%20APH%20Movel.pdf.
13. Instituto Brasileiro de Geografia e Estatística (IBGE). Tábuas completas de Mortalidade. [Acesso em 2007 jan 17]. Disponível em http://www.ibge.gov.br/home/estatistica/populacao/ tabuadevida/2005/default.shtm..
14. Oxford Centre for Evidence Based Medicine: projeto diretrizes. [Acesso em 2007 jan 17]. Disponível em http://www.projetodiretrizes.org.br/ projetodiretrizes/textointrodutorio.pdf
15. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003; 24 (1): 28-66.
16. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the ACC/AHA Task Force on practice guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation. 2004; 110 (9): e82-292.
17. Armstrong PW, Bogaty P, Buller CE, Dorian P, O'Neill BJ, Canadian Cardiovascular Society Working Group. The 2004 ACC/AHA guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. Can J Cardiol. 2004; 20 (11): 1075-9.
18. Avezum A, Piegas LS, Pereira JC. Risk factors associated with acute myocardial infarction in the Sao Paulo metropolitan region: a developed region in a developing country. Arq Bras Cardiol. 2005; 84 (3): 206-13.
19. Murray CJL, Salomon J, Mathers CD, Lopez AD. Summary measures of population health: concepts, ethics, measurement and applications: non serial publications. Geneva; WHO; 2002.